Biopharmaceutical News and Research

RSS
Advanced Life Sciences enters CRADA for Restanza with Walter Reed Army Institute of Research

Advanced Life Sciences enters CRADA for Restanza with Walter Reed Army Institute of Research

2 Nov 2010
Soligenix completes enrollment in RiVax Phase 1B ricin toxin clinical trial

Soligenix completes enrollment in RiVax Phase 1B ricin toxin clinical trial

2 Nov 2010
VaxInnate’s prototype flu vaccine named as Top 10 Infectious Diseases Projects to Watch in 2011

VaxInnate’s prototype flu vaccine named as Top 10 Infectious Diseases Projects to Watch in 2011

2 Nov 2010
Eli Lilly's new research center to focus on diabetes in China

Eli Lilly's new research center to focus on diabetes in China

2 Nov 2010
BioCancell's Phase I/IIa clinical trial of BC-819 shows positive result for pancreatic cancer

BioCancell's Phase I/IIa clinical trial of BC-819 shows positive result for pancreatic cancer

2 Nov 2010
Access Pharmaceuticals receives $1.5 million in government grants

Access Pharmaceuticals receives $1.5 million in government grants

2 Nov 2010
PAREXEL first quarter revenue increases 13.9% to $295.8 million

PAREXEL first quarter revenue increases 13.9% to $295.8 million

From Parexel 2 Nov 2010
GOG to initiate combination elesclomol-paclitaxel Phase 2 clinical trial for ovarian cancer

GOG to initiate combination elesclomol-paclitaxel Phase 2 clinical trial for ovarian cancer

1 Nov 2010
America's biopharmaceutical companies researching 98 medicines for Alzheimer's: PhRMA report

America's biopharmaceutical companies researching 98 medicines for Alzheimer's: PhRMA report

1 Nov 2010
NeoPharm enters merger agreement with Insys Therapeutics

NeoPharm enters merger agreement with Insys Therapeutics

30 Oct 2010
Agilent opens new life sciences instruments manufacturing facility in Singapore

Agilent opens new life sciences instruments manufacturing facility in Singapore

30 Oct 2010
AVEO to raise $61 million through private placement

AVEO to raise $61 million through private placement

30 Oct 2010
Idenix third quarter total revenue increases from $3.1 million to $3.8 million

Idenix third quarter total revenue increases from $3.1 million to $3.8 million

30 Oct 2010
Shire announces results of Vyvanse Phase 2 signal finding study for Major Depressive Disorder

Shire announces results of Vyvanse Phase 2 signal finding study for Major Depressive Disorder

29 Oct 2010
Coadministration of INTUNIV tablets with stimulant reduces ADHD symptoms

Coadministration of INTUNIV tablets with stimulant reduces ADHD symptoms

29 Oct 2010
Emergent BioSolutions completes Trubion acquisition

Emergent BioSolutions completes Trubion acquisition

29 Oct 2010
Pain Therapeutics third quarter net loss decreases from $1.3 million to $1.0 million

Pain Therapeutics third quarter net loss decreases from $1.3 million to $1.0 million

29 Oct 2010
Bioniche ranked #14 on Top 50 Best Small and Medium Employers in Canada

Bioniche ranked #14 on Top 50 Best Small and Medium Employers in Canada

28 Oct 2010
AnaptysBio announces issuance of two new patents for SHM-XEL platform

AnaptysBio announces issuance of two new patents for SHM-XEL platform

28 Oct 2010
Ipsen reports 8.3% increase in Group sales for first nine months of 2010

Ipsen reports 8.3% increase in Group sales for first nine months of 2010

28 Oct 2010

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback